Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tenofovir / therapeutic use"'
Autor:
Bernard Surial, Thanh Doco-Lecompte, Hansjakob Furrer, Charles Béguelin, Gilles Wandeler, Marcel Stöckle, Jan Fehr, Andri Rauch, Enos Bernasconi, Jean-Philippe Chave, Laura N Walti, Patrick Schmid, Noémie Boillat-Blanco, Huldrych F. Günthard
Publikováno v:
Journal of acquired immune deficiency syndromes, vol. 85, no. 2, pp. 227-232
Journal of Acquired Immune Deficiency Syndromes (1999)
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Background: Whereas tenofovir disoproxil fumarate (TDF) can lead to renal adverse events, tenofovir alafenamide (TAF) has a more favorable renal safety profile. However, the impact of replac
Background: Whereas tenofovir disoproxil fumarate (TDF) can lead to renal adverse events, tenofovir alafenamide (TAF) has a more favorable renal safety profile. However, the impact of replac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca2994d50dcb69a3583b817f037786c8
https://pubmed.ncbi.nlm.nih.gov/32925387
https://pubmed.ncbi.nlm.nih.gov/32925387
Autor:
Huldrych F. Günthard, Alexandra Calmy, Patrick Schmid, Andri Rauch, Franziska Suter-Riniker, Nicole Friolet, Gilles Wandeler, Roland Sahli, Andrew Atkinson, Enos Bernasconi, Alexander Lüthi, Matthias Cavassini, Darius Moradpour, Manuel Battegay, Charles Béguelin
Publikováno v:
Clinical Infectious Diseases, Vol. 64, No 9 (2017) pp. 1275-1278
We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38215c7a115069308084fae5c8291206
https://doi.org/10.1093/cid/cix125
https://doi.org/10.1093/cid/cix125
Autor:
Surial, Bernard, Cavassini, Matthias, Calmy, Alexandra, Fehr, Jan, Stöckle, Marcel, Bernasconi, Enos, Roth, Bianca, Fux, Christoph A, Kovari, Helen, Furrer, Hansjakob, Rauch, Andri, Wandeler, Gilles, Swiss HIV Cohort Study
Publikováno v:
BMC infectious diseases, vol. 19, no. 1, pp. 834
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases
Surial, Bernard; Cavassini, Matthias; Calmy, Alexandra; Fehr, Jan; Stöckle, Marcel; Bernasconi, Enos; Roth, Bianca; Fux, Christoph A; Kovari, Helen; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC infectious diseases, 19(1), p. 834. BioMed Central 10.1186/s12879-019-4454-9
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases
Surial, Bernard; Cavassini, Matthias; Calmy, Alexandra; Fehr, Jan; Stöckle, Marcel; Bernasconi, Enos; Roth, Bianca; Fux, Christoph A; Kovari, Helen; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC infectious diseases, 19(1), p. 834. BioMed Central 10.1186/s12879-019-4454-9
BackgroundTenofovir alafenamide (TAF)-containing combinations were introduced in Switzerland after October 2016 and are recommended over tenofovir disoproxil fumarate (TDF) in patients with osteoporosis or impaired renal function.MethodsWe included a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e4872fd47d082fd5c4208de5eb56dc
https://serval.unil.ch/resource/serval:BIB_33535700F126.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_33535700F126.P001/REF.pdf
Autor:
Venter, Willem Daniel Francois, Kambugu, Andrew, Chersich, Matthew F, Becker, Stephen, Hill, Andrew, Arulappan, Natasha, Moorhouse, Michelle, Majam, Mohammed, Akpomiemie, Godspower, Sokhela, Simiso, Poongulali, Selvamuthu, Feldman, Charles, Duncombe, Chris, Ripin, David H Brown, Vos, Alinda, Kumarasamy, Nagalingeswaran
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes, 80(2), 224. Lippincott Williams and Wilkins
Background:Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities of tenofovir disoproxil fumarate (TDF).Setting:HIV-1-infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f3fe52d807512b457bb6a261f9a4951b
https://dspace.library.uu.nl/handle/1874/388745
https://dspace.library.uu.nl/handle/1874/388745
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes. 80(2):224
Background:Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities of tenofovir disoproxil fumarate (TDF).Setting:HIV-1-infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::b843869ebb9d0b765d906bf50ffc6e03
https://hdl.handle.net/1874/388745
https://hdl.handle.net/1874/388745
Autor:
Eric Florence, Jens D Lundgren, P. Gargalianos-Kakolyris, Court Pedersen, Fernando Maltez, V. Uzdaviniene, Thérèse Staub, for EuroSIDA, Jennifer F Hoy, Leo Flamholc, G. Kyselyova, Hans Jürgen Stellbrink, Rainer Weber, J Tomazic, Chloe Orkin, Anna Lisa Ridolfo, Fiona Mulcahy, Christian Pradier, Patrick Schmid, Dalibor Sedláček, Álvaro H. Borges, Amanda Mocroft, Clifford Leen
Publikováno v:
Borges, Á H, Hoy, J F, Florence, E, Sedlacek, D, Stellbrink, H-J, Uzdaviniene, V, Tomazic, J, Gargalianos-Kakolyris, P, Schmid, P, Orkin, C, Pedersen, C, Leen, C, Pradier, C, Mulcahy, F, Ridolfo, A L, Staub, T, Maltez, F, Weber, R, Flamholc, L, Kyselyova, G, Lundgren, J D, Mocroft, A & for EuroSIDA 2017, ' Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort ', Clinical Infectious Diseases, vol. 64, no. 10, pp. 1413-1421 . https://doi.org/10.1093/cid/cix167
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Background: Antiretrovirals (ARVs) affect bone density and turnover, but their effect on risk of fractures and osteonecrosis of the femoral head is less understood. We investigated if exposure to ARVs increases the risk of both bone outcomes. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192623243970f6512cea9fa1488b96bd
https://findresearcher.sdu.dk:8443/ws/files/141377132/Antiretrovirals_Fractures_and_Osteonecrosis_in_a_Large_International_HIV_Cohort.pdf
https://findresearcher.sdu.dk:8443/ws/files/141377132/Antiretrovirals_Fractures_and_Osteonecrosis_in_a_Large_International_HIV_Cohort.pdf
Autor:
Sculier, Delphine, Gayet-Ageron, Angèle, Battegay, Manuel, Cavassini, Matthias, Fehr, Jan, Hirzel, Cedric, Schmid, Patrick, Bernasconi, Enos, Calmy, Alexandra, Swiss HIV Cohort Study
Publikováno v:
BMC Infectious Diseases, Vol. 17, No 1 (2017) P. 476
Sculier, Delphine; Gayet-Ageron, Angèle; Battegay, Manuel; Cavassini, Matthias; Fehr, Jan; Hirzel, Cédric; Schmid, Patrick; Bernasconi, Enos; Calmy, Alexandra (2017). Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study. BMC infectious diseases, 17(1), p. 476. BioMed Central 10.1186/s12879-017-2579-2
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-10 (2017)
BMC infectious diseases, vol. 17, no. 1, pp. 476
BMC Infectious Diseases
Sculier, Delphine; Gayet-Ageron, Angèle; Battegay, Manuel; Cavassini, Matthias; Fehr, Jan; Hirzel, Cédric; Schmid, Patrick; Bernasconi, Enos; Calmy, Alexandra (2017). Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study. BMC infectious diseases, 17(1), p. 476. BioMed Central 10.1186/s12879-017-2579-2
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-10 (2017)
BMC infectious diseases, vol. 17, no. 1, pp. 476
BMC Infectious Diseases
Background Rilpivirine is safe and effective in HIV-naïve patients with low baseline HIV-RNA or in switch strategy. It offers the advantages of few drug-drug interactions and a favourable toxicity profile. We aimed to determine the reasons for presc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86e16acbaa4b9e34de8caf9addf2e94
https://archive-ouverte.unige.ch/unige:112377
https://archive-ouverte.unige.ch/unige:112377
Autor:
Raymond Farkouh, Mike Chambers, Penny Maroudas, Maria E. Watson, Teresa L. Kauf, Stephanie R. Earnshaw
Publikováno v:
PharmacoEconomics. 28(11):1025-1039
Background: Abacavir sulfate (abacavir) is associated with a hypersensitivity reaction (HSR) that affects 5-8% of patients. While serious complications are rare, failure to identify it, or abacavir re-challenge following HSR, can be fatal. Genetic sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a94f1dc1a4b4f5203387e4dadb985671
http://PharmacoEconomics.adisonline.com/pt/re/pec/fulltext.00019053-201028110-00007.htm
http://PharmacoEconomics.adisonline.com/pt/re/pec/fulltext.00019053-201028110-00007.htm
Autor:
Florian, Bihl, Gladys, Martinetti, Gilles, Wandeler, Rainer, Weber, Bruno, Ledergeber, Alexandra, Calmy, Manuel, Battegay, Matthias, Cavassini, Pietro, Vernazza, Anna-Paola, Caminada, Martin, Rickenbach, Enos, Bernasconi, S, Yerly
Publikováno v:
Bihl, Florian; Martinetti, Gladys; Wandeler, Gilles; Weber, Rainer; Ledergeber, Bruno; Calmy, Alexandra; Battegay, Manuel; Cavassini, Matthias; Vernazza, Pietro; Caminada, Anna-Paola; Rickenbach, Martin; Bernasconi, Enos (2015). HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons. BMC gastroenterology, 15(1), p. 79. BioMed Central 10.1186/s12876-015-0308-0
BMC Gastroenterology
Bmc Gastroenterology, vol. 15, pp. 79
BMC Gastroenterology
Bmc Gastroenterology, vol. 15, pp. 79
BACKGROUND: Hepatitis B virus (HBV) genotypes can influence treatment outcome in HBV-monoinfected and human immunodeficiency virus (HIV)/HBV-coinfected patients. Tenofovir disoproxil fumarate (TDF) plays a pivotal role in antiretroviral therapy (ART)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f3992329a8aad0c2bae9eeece0c682
https://boris.unibe.ch/70336/1/12876_2015_Article_308.pdf
https://boris.unibe.ch/70336/1/12876_2015_Article_308.pdf